Literature DB >> 8785617

Evaluation of 1H magnetic resonance spectroscopic imaging as a diagnostic tool for the lateralization of epileptogenic seizure foci.

I Constantinidis1, J A Malko, S B Peterman, R C Long, C M Epstein, D Boor, J C Hoffman, L Shutter, J D Weissman.   

Abstract

The purpose of this study was to assess whether a visual examination of 1H spectroscopic images could correctly lateralize patients with intractable temporal lobe epilepsy. 20 patients with intractable temporal lobe epilepsy and 10 volunteers were included in this study. Spectroscopic images were analysed using a protocol based on visual inspection. Images of the metabolites N-acetyl aspartate (NAA), choline (Cho), creatine (Cr) and lactate were obtained from a transverse plane oriented along the sylvian fissure. Images from each individual were evaluated independently by six reviewers. Results of the lateralization procedure obtained from the visual examinations were compared with those obtained from quantitative analysis of the spectra and with those obtained by magnetic resonance imaging (MRI), positron emission tomography (PET), neuropsychological examinations, and electroencephalographic (EEG) recordings. NAA images were found to be the most effective, amongst metabolite images, in lateralizing the epileptogenic lobe. Using the site selected for resection as the definition of the correct lateralization, 70% of the patients who underwent temporal lobectomy were correctly lateralized by the majority of the examiners using the visual inspection protocol. Based on the results of this study it is concluded that visual examination of 1H spectroscopic images is potentially valid in lateralizing patients with intractable temporal lobe seizures. Confidence in the visual interpretation increased as the difference in NAA signal intensity between the temporal lobes increased. The threshold above which the majority of the examiners correctly lateralized the patients was approximately 15% in NAA signal loss in the ipsilateral lobe.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8785617     DOI: 10.1259/0007-1285-69-817-15

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  7 in total

1.  Effect of seizure on hippocampus in mesial temporal lobe epilepsy and neocortical epilepsy: an MRS study.

Authors:  S K Lee; D W Kim; K K Kim; C K Chung; I C Song; K H Chang
Journal:  Neuroradiology       Date:  2005-09-13       Impact factor: 2.804

2.  Usefulness of single voxel proton MR spectroscopy in the evaluation of hippocampal sclerosis.

Authors:  K H Chang; H D Kim; S W Park; I C Song; I K Yu; M H Han; S K Lee; C K Chung; Y H Park
Journal:  Korean J Radiol       Date:  2000 Jan-Mar       Impact factor: 3.500

3.  Magnetization transfer imaging and proton MR spectroscopy in the evaluation of axonal injury: correlation with clinical outcome after traumatic brain injury.

Authors:  G Sinson; L J Bagley; K M Cecil; M Torchia; J C McGowan; R E Lenkinski; T K McIntosh; R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

4.  Temporal lobe epilepsy: qualitative reading of 1H MR spectroscopic images for presurgical evaluation.

Authors:  A A Capizzano; P Vermathen; K D Laxer; G R Ende; D Norman; H Rowley; G B Matson; A A Maudsley; M R Segal; M W Weiner
Journal:  Radiology       Date:  2001-01       Impact factor: 11.105

5.  Lateralizing ability of single-voxel proton mr spectroscopy in hippocampal sclerosis: comparison with mr imaging and positron emission tomography.

Authors:  S W Park; K H Chang; H D Kim; I C Song; D S Lee; S K Lee; C K Chung; I K Yu; M H Han; Y H Park
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

6.  Novel approaches to imaging epilepsy by MRI.

Authors:  Hoby Hetherington
Journal:  Future Neurol       Date:  2009-05-01

Review 7.  1H MR spectroscopy in patients with mesial temporal epilepsy.

Authors:  M Hájek; M Dezortová; V Komárek
Journal:  MAGMA       Date:  1998-12       Impact factor: 2.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.